FDA Approved: CEFTRIAXONE AND DEXTROSE — Supplemental Application (B. Braun Medical Inc.)

View source ↗

Summary

FDA approved a supplemental application for Ceftriaxone and Dextrose from B. Braun Medical, resulting in an updated/expanded approval for this product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Community-acquired Pneumonia
• Gonorrhea
• Intra-abdominal Infection
• Meningitis
• Osteomyelitis
• Pelvic Inflammatory Disease
• Sepsis
• Skin and Soft Tissue Infection

Drugs mentioned

• CEFTRIAXONE AND DEXTROSE (Ceftriaxone)

Snippet

SUPPL AP for CEFTRIAXONE AND DEXTROSE (CEFTRIAXONE)